Endovascular treatment of vertebral artery-origin and innominate/subclavian disease: indications and technique.

Endovascular treatment of vertebral artery-origin and innominate/subclavian disease: indications and technique. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Endovascular treatment of vertebral artery-origin and innominate/subclavian disease: indications and technique. Abstract Text:

Guilherme Dabus,Christopher J Moran,Colin P Derdeyn,Dewitte T Cross,Guilherme Dabus,Christopher J Moran,Colin P Derdeyn,Dewitte T Cross,

Approximately 20% to 40% of patients who have cerebral vascular disease have a vertebral artery-origin stenosis. Atherosclerotic lesions of vertebral arety origin are a potential cause of posterior circulation ischemia, which can be disabling or deadly. Endovascular treatment of vertebral artery-origin and innominate/subclavian artery stenosis has changed in the last 15 years. Surgery usually is successful technically; however, it is also associated with high rates of procedural and periprocedural complications. New techniques and technologies that can be used in the treatment of such lesions are being developed. In this article, the authors discuss the indications, technical aspects, and long-term results of angioplasty and stenting of these vessels.

Endovascular treatment of vertebral artery-origin and innominate/subclavian disease: indications and technique. Publishing Authors By Initials

G Dabus,CJ Moran,CP Derdeyn,DT Cross,G Dabus,CJ Moran,CP Derdeyn,DT Cross,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Endovascular treatment of vertebral artery-origin and innominate/subclavian disease: indications and technique. Journal Published:

PUBLICATION TYPE: Review

Journal: Neuroimaging clinics of North America

VOLUME: 17

Page Numbers: 381-92, ix

Journal Abbreviation: Neuroimaging Clin. N. Am.

ISSN: 1052-5149

DAY: 10

MONTH: Aug

YEAR: 2007

Endovascular treatment of vertebral artery-origin and innominate/subclavian disease: indications and technique. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9211377

Endovascular treatment of vertebral artery-origin and innominate/subclavian disease: indications and technique. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Endovascular treatment of vertebral artery-origin and innominate/subclavian disease: indications and technique. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Endovascular treatment of vertebral artery-origin and innominate/subclavian disease: indications and technique.

AFFILIATION: Division of Interventional Neuroradiology, Gray 241, Massachusetts General Hospital - Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA. gdabus@partners.org

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Neuroimaging Clin N Am

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Endovascular treatment of vertebral artery-origin and innominate/subclavian disease: indications and technique Related Publications

• A Viral Envelope as a Vehicle for Tracer, Drug, and Gene Delivery: Initial Biodistribution Study Using PET Imaging.
• Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathways.
• Apoptosis-associated changes in the glycerophospholipid composition of hematopoietic progenitor cells monitored by 31P NMR spectroscopy and MALDI-TOF mass spectrometry.
• Backbone structure of the amantadine-blocked trans-membrane domain M2 proton channel from Influenza A virus.
• Community sexually transmitted infection services are good enough: a qualitative study of clients' experiences.
• Consequences of telomere shortening at an active VSG expression site in telomerase-deficient Trypanosoma brucei.
• Cyclin and cyclin-dependent kinase substrate requirements for preventing rereplication reveal the need for concomitant activation and inhibition.
• Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. D. McCormick H. Chong, C. Hobbs, C. Datta & P. A. Hall. Histopathology 1993; 22; 355-360.
• Diagnostic and therapeutic management of eosinophilia-associated chronic myeloproliferative disorders.
• Diet and risk of multiple myeloma in Connecticut women.
• Endovascular treatment of vertebral artery-origin and innominate/subclavian disease: indications and technique.
• Expert commentary.
• Expert commentary.
• Further evidence of attention bias for negative information in late life depression.
• Genome-wide screening of alpha-tocopherol sensitive genes in heart tissue from alpha-tocopherol transfer protein null mice (ATTP(-/-)).
• Higher IgG index found in African Americans versus Caucasians with multiple sclerosis.
• Histone modifications in Trypanosoma brucei.
• Laser hair removal.
• Maintaining eye care services during times of conflict.
• Methylation-sensitive high-resolution melting-curve analysis of the SNRPN gene as a diagnostic screen for Prader-Willi and Angelman syndromes.
• Morbidity profiles of patients consulting during influenza and respiratory syncytial virus active periods.
• Percutaneous absorption of topically applied NSAIDS and other compounds: Role of solute properties, skin physiology and delivery systems.
• Protective role of Bacillus anthracis exosporium in macrophage-mediated killing by nitric oxide.
• Role of Bacillus anthracis spore structures in macrophage cytokine responses.
• Salivary hormones and parturition in healthy, primigravid women.
• Single-institution experience with matrix coils in the treatment of intracranial aneurysms: comparison with same-center outcomes with the use of platinum coils.
• The chemical and dynamical influence of the anti-viral drug amantadine on the M2 proton channel transmembrane domain.
• Uniformly aligned full-length membrane proteins in liquid crystalline bilayers for structural characterization.
• Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition.
• [Application of denaturing high performance liquid chromatography to mutation detection of the c-kit gene in mastocytosis]